The influence of lentivirus-mediated CXCR4 RNA interference on hepatic metastasis of colorectal cancer

International Journal of Oncology

Volumn 45, Issue 6, 2014, Pages 1861-1869

  Wang, Tian Bao ^a   Hu, Bao Guang ^b   Liu, Da Wei ^a   Shi, Han Ping ^a   Dong, Wen Guang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CXCR4; Hepatic metastasis; Lentivirus; RNA interference; SW480 cell

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; LENTIVIRUS CXCR4 SMALL INTERFERING RNA; LENTIVIRUS VECTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL COUNT; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; LIVER METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; COLORECTAL TUMOR; EXPERIMENTAL NEOPLASM; GENE VECTOR; GENETICS; HUMAN; LENTIVIRINAE; LIVER TUMOR; METABOLISM; PATHOLOGY; SECONDARY; TUMOR CELL LINE; CELL GROWTH; CELL PROLIFERATION; HUMAN CELL;

ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENETIC VECTORS; HUMANS; LENTIVIRUS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; RECEPTORS, CXCR4; RNA INTERFERENCE;

EID: 84899503575     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2348     Document Type: Article

References (44)

1. Wichmann MW, Beukes E, Esufali ST, Plaumann L and Maddern G: Five-year results of surgical colorectal cancer treatment in rural Australia. ANZ J Surg 83: 112-117, 2013.
2. Shin HN, Moon HH and Ku JL: Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells. Int J Mol Med 30: 1537-1543, 2012.
3. Yasuoka H, Kodama R, Hirokawa M, Takamura Y, Miyauchi A, Sanke T and Nakamura Y: CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis. BMC Cancer 8: 274, 2008.
4. Cavallaro S: CXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brain. Int J Mol Sci 14: 1713-1727, 2013.
5. Sekiya R, Kajiyama H, Sakai K, Umezu T, Mizuno M, Shibata K, Yamamoto E, Fujiwara S, Nagasaka T and Kikkawa F: Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary. Hum Pathol 43: 904-910, 2012.
6. Jung SJ, Kim CI, Park CH, Chang HS, Kim BH, Choi MS and Jung HR: Correlation between chemokine receptor CXCR4 expression and prognostic factors in patients with prostate cancer. Korean J Urol 52: 607-611, 2011.
7. Wang L, Huang T, Chen W, Gao X, Zhou T, Wu Z and Sun Y: Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells. Oncol Rep 28: 2043-2048, 2012.
8. Gros SJ, Kurschat N, Drenckhan A, Dohrmann T, Forberich E, Effenberger K, Reichelt U, Hoffman RM, Pantel K, Kaifi JT and Izbicki JR: Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophagealcancer. PLoS One 7: e47287, 2012.
9. Zhong W, Chen W, Zhang D, Sun J, Li Y, Zhang J, Gao Y, Zhou W and Li S: CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: a clinical study. Exp Ther Med 4: 363-369, 2012.
10. Lee HJ and Jo DY: The role of the CXCR4/CXCL12 axis and its clinical implications in gastric cancer. Histol Histopathol 27: 1155-1161, 2012.
11. Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ, Wang H, Wang Y, Li R, Yang Y, Zhao X,Xu XD, Yu ED, Rui YC, Liu HJ, Zhang L and Wei LX: CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients. BMC Med 10: 85, 2012.
12. Wang TB, Chen ZG, Wei XQ, Wei B and Dong WG: Serum vascular endothelial growth factor-C and lymphangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer. ANZ J Surg 81: 894-899, 2011.
13. De Falco V, Guarino V, Avilla E, Castellone MD, Salerno P, Salvatore G, FavianaP, Basolo F, Santoro M and Melillo RM: Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer. Cancer Res 67: 11821-11829, 2007.
14. Li JK, Yu L, Shen Y, Zhou LS, Wang YC and Zhang JH: Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro. World J Gastroenterol 14: 2308-2313, 2008.
15. Kim JM, Lee YH, Ku CR and Lee EJ: The cyclic pentapeptide d-Arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude mice. Endocrinology 152: 536-544, 2011.
16. Murakami T, Kawada K, Iwamoto M, Akagami M, Hida K, Nakanishi Y, Kanda K, Kawada M, Seno H, Taketo MM and Sakai Y: The role of CXCR3 and CXCR4 in colorectal cancer metastasis. Int J Cancer 132: 276-287, 2013.
17. Heckmann D, Laufs S, Maier P, Zucknick M, Giordano FA, Veldwijk MR, Eckstein V, Wenz F, Zeller WJ, Fruehauf S and Allgayer H: A lentiviral CXCR4 overexpression and knockdown model in colorectal cancer cell lines reveals plerixafor-dependent suppression of SDF-1α-induced migration and invasion. Onkologie 34: 502-508, 2011.
18. Liang Z, Yoon Y, Votaw J, Goodman MM, Williams L and Shim H: Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res 65: 967-971, 2005.
19. Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D and Luker GD: CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 8604-8612, 2004.
20. Liang Z, Wu H, Reddy S, Zhu A, Wang S, Blevins D, Yoon Y, Zhang Y and Shim H: Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA. Biochem Biophys Res Commun 363: 542-546, 2007.
21. Beverly AT and Simon PF: CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16: 2927-2931, 2010.
22. Meads MB, Hazlehurst LA and Dalton WS: The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res 14: 2519-2526, 2008.
23. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 4: 540-550, 2004.
24. Petit I, Jin D and Rafii S: The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 28: 299-307, 2007.
25. Rubie C, Frick VO, Ghadjar P, Wagner M, Justinger C, Faust SK, Vicinus B, Gräber S, Kollmar O and Schilling MK: CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells. J Transl Med 9: 22, 2011.
26. Wang SC, Lin JK, Wang HS, Yang SH, Li AF and Chang SC: Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int J Colorectal Dis 25: 1185-1191, 2010.
27. Fukunaga S, Maeda K, Noda E, Inoue T, Wada K and Hirakawa K: Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer. Oncology 71: 204-211, 2006.
28. Matsusue R, Kubo H, Hisamori S, Okoshi K, Takagi H, Hida K, Nakano K, Itami A, Kawada K, Nagayama S and Sakai Y: Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol 16: 2645-2653, 2009.
29. Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, Tosteson TD and Pipas JM: Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. Clin Colorectal Cancer 8: 100-105, 2009.
30. Speetjens FM, Liefers GJ, Korbee CJ, Mesker WE, van de Velde CJ, van Vlierberghe RL, Morreau H, Tollenaar RA and Kuppen PJ: Nuclear localization of CXCR4 determines prognosis for colorectal cancer patients. Cancer Microenviron 2: 1-7, 2009.
31. Brand S, Dambacher J, Beigel F, Olszak T, Diebold J, Otte JM, Göke B and Eichhorst ST: CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310: 117-130, 2005.
32. Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ieranò C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R and Scala S: Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin Cancer Res 12: 2795-2803, 2006.
33. Zhu Y, Yang P, Zhang X, Zhang L, Cui G, Wang Q, Lv L, Zhang Y, Xin X, Yan T, Zhao M and Zhang N: The effect and mechanism of CXCR4 silencing on metastasis suppression of human glioma u87 cell line. Anat Rec (Hoboken) 296: 1857-1864, 2013.
34. Shen B, Zheng MQ, Lu JW, Jiang Q, Wang TH and Huang XE: CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancer cells. Asian Pac J Cancer Prev 14: 5403-408, 2013.
35. Sun X, Charbonneau C, Wei L, Yang W, Chen Q and Terek RM: CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis. Mol Cancer Ther 12: 1163-1170, 2013.
36. Wang B, Wang W, Niu W, Liu E, Liu X, Wang J, Peng C, Liu S, Xu L, Wang L and Niu J: SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6. Carcinogenesis 35: 282-291, 2014.
37. Xue B, Wu W, Huang K, Xie T, Xu X, Zhang H, Qi C, Ge J and Yu Y: Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer. Mol Cell Biochem 380: 177-184, 2013.
38. Kiss DL, Windus LC and Avery VM: Chemokine receptor expression on integrin-mediated stellate projections of prostate cancer cells in 3D culture. Cytokine 64: 122-130, 2013.
39. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ and Conklin DS: Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16: 948-958, 2002.
40. De Maria R, Miretti S, Iussich S, Olivero M, Morello E, Bertotti A, Christensen JG, Biolatti B, Levine RA, Buracco P and Di Renzo MF: Met oncogene activation qualifies spontaneous canine steosarcoma as a suitable pre-clinical model of human steosarcoma. J Pathol 218: 399-408, 2009.
41. Chen D, Huang H, Pan C, Wang J, Zhang B and Wang A: Antitumor effects of targeting hTERT lentivirus-mediated RNA interference against KB cell lines. Oncol Res 17: 621-630, 2009.
42. Chunkang C, Rui Y, Feng X, Juan G, Xi Z, Lingyun W, Xiao L and Jianmin W: The roles of SDF-1/CXCR4 axis and its relationship with apoptosis in the myelodysplastic syndromes. Med Oncol 28 (Suppl 1): 494-500, 2011.
43. Yu T, Wu Y, Huang Y, Yan C, Liu Y, Wang Z, Wang X, Wen Y, Wang C and Li L: RNAi targeting CXCR4 inhibits tumor growth through inducing cell cycle arrest and apoptosis. Mol Ther 20: 398-407, 2012.
44. Wang Q, Diao X, Sun J and Chen Z: Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line. Cell Biol Int 35: 897-904, 2011.